366 related articles for article (PubMed ID: 20500986)
1. Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.
Rivera J; Sobey CG; Walduck AK; Drummond GR
Redox Rep; 2010; 15(2):50-63. PubMed ID: 20500986
[TBL] [Abstract][Full Text] [Related]
2. Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease.
Touyz RM; Anagnostopoulou A; Camargo LL; Rios FJ; Montezano AC
Antioxid Redox Signal; 2019 Mar; 30(7):1027-1040. PubMed ID: 30334629
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidases in vascular pathology.
Konior A; Schramm A; Czesnikiewicz-Guzik M; Guzik TJ
Antioxid Redox Signal; 2014 Jun; 20(17):2794-814. PubMed ID: 24180474
[TBL] [Abstract][Full Text] [Related]
4. Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond GR; Sobey CG
Trends Endocrinol Metab; 2014 Sep; 25(9):452-63. PubMed ID: 25066192
[TBL] [Abstract][Full Text] [Related]
5. The Nox family of NADPH oxidases: friend or foe of the vascular system?
Takac I; Schröder K; Brandes RP
Curr Hypertens Rep; 2012 Feb; 14(1):70-8. PubMed ID: 22071588
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.
Kawahara T; Ritsick D; Cheng G; Lambeth JD
J Biol Chem; 2005 Sep; 280(36):31859-69. PubMed ID: 15994299
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidases in cardiovascular health and disease.
Cave AC; Brewer AC; Narayanapanicker A; Ray R; Grieve DJ; Walker S; Shah AM
Antioxid Redox Signal; 2006; 8(5-6):691-728. PubMed ID: 16771662
[TBL] [Abstract][Full Text] [Related]
8. Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells.
Yu P; Han W; Villar VA; Yang Y; Lu Q; Lee H; Li F; Quinn MT; Gildea JJ; Felder RA; Jose PA
Redox Biol; 2014; 2():570-9. PubMed ID: 24688893
[TBL] [Abstract][Full Text] [Related]
9. Mammalian NADPH Oxidases.
Buvelot H; Jaquet V; Krause KH
Methods Mol Biol; 2019; 1982():17-36. PubMed ID: 31172464
[TBL] [Abstract][Full Text] [Related]
10. Targeting NADPH oxidases in vascular pharmacology.
Schramm A; Matusik P; Osmenda G; Guzik TJ
Vascul Pharmacol; 2012; 56(5-6):216-31. PubMed ID: 22405985
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.
Di Marco E; Gray SP; Chew P; Kennedy K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Clin Sci (Lond); 2016 Aug; 130(15):1363-74. PubMed ID: 27190136
[TBL] [Abstract][Full Text] [Related]
12. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology.
Bengtsson SH; Gulluyan LM; Dusting GJ; Drummond GR
Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):849-54. PubMed ID: 14678249
[TBL] [Abstract][Full Text] [Related]
13. NOX Inhibitors: From Bench to Naxibs to Bedside.
Elbatreek MH; Mucke H; Schmidt HHHW
Handb Exp Pharmacol; 2021; 264():145-168. PubMed ID: 32780287
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.
Rezende F; Prior KK; Löwe O; Wittig I; Strecker V; Moll F; Helfinger V; Schnütgen F; Kurrle N; Wempe F; Walter M; Zukunft S; Luck B; Fleming I; Weissmann N; Brandes RP; Schröder K
Free Radic Biol Med; 2017 Jan; 102():57-66. PubMed ID: 27863990
[TBL] [Abstract][Full Text] [Related]
16. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Drummond GR; Selemidis S; Griendling KK; Sobey CG
Nat Rev Drug Discov; 2011 Jun; 10(6):453-71. PubMed ID: 21629295
[TBL] [Abstract][Full Text] [Related]
17. The role of NADPH oxidase in vascular disease--hypertension, atherosclerosis & stroke.
Gray SP; Jandeleit-Dahm KA
Curr Pharm Des; 2015; 21(41):5933-44. PubMed ID: 26510435
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidases: functions and pathologies in the vasculature.
Lassègue B; Griendling KK
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):653-61. PubMed ID: 19910640
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Glucose Homeostasis and Diabetes-Related Endothelial Cell Dysfunction.
Brown OI; Bridge KI; Kearney MT
Cells; 2021 Sep; 10(9):. PubMed ID: 34571964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
